Navigation Links
Clinical Data for BackBeat Medical's Programmable Hypertension Control Therapy to Be Presented at ICI Meeting 2016
Date:11/29/2016

NEW HOPE, Pa., Nov. 29, 2016 /PRNewswire/ -- BackBeat Medical Inc., a medical technology company developing novel cardiac stimulation-based therapies for hypertension and heart failure, today announced that clinical data for the company's patented Programmable Hypertension Control (PHC) therapy will be presented at the Innovations in Cardiovascular Interventions (ICI) Meeting 2016, Dec. 4-6, in Tel Aviv, Israel.

The presentation will feature results from the first-in-man study of BackBeat's PHC therapy including two years of follow-up data from patients who received BackBeat's Moderato™ pacemaker incorporating the company's proprietary pacing algorithms. Dr. Yuval Mika, CEO and co-founder, will deliver the presentation "Programmable Hypertension Control (PHC) - A Pacemaker-Mediated Novel Approach for the Treatment of Hypertension" during the session "Technology Parade I - Devices" at 9:50 a.m. IST on Monday, Dec. 5 in Room 4 at the David Intercontinental Convention Center.

About BackBeat Medical

BackBeat Medical Inc. is a medical technology company founded in 2010 to develop novel cardiac stimulation-based therapies for hypertension and heart failure. BackBeat has developed a patented cardiac pacing-based treatment for hypertension (HTN) called programmable hypertension control (PHC) therapy. PHC is comprised of proprietary pacing algorithms that can be readily incorporated into standard pacemakers using standard leads and standard lead placement and thus has broad applicability. PHC offers a new potent device-based HTN therapeutic alternative potentially opening up a large market to treat HTN patients, particularly HTN patients who already have or require a pacemaker. Clinical results generated to date using BackBeat's own Moderato™ pacemaker incorporating PHC algorithms demonstrate that this therapy has a substantial and sustained therapeutic effect on blood pressure as determined by both in-office cuff measurements (average reduction of 24 mmHg from baseline) and 24-hour ambulatory measurements (average reduction of 14 mmHg from baseline) with clinical follow up extending up to two years.

Media Contacts:                                                                              

David Schull or Todd Davenport, Ph.D.
Russo Partners, LLC
(212) 845-4271
(212) 845-4235
david.schull@russopartnersllc.com 
todd.davenport@russopartnersllc.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clinical-data-for-backbeat-medicals-programmable-hypertension-control-therapy-to-be-presented-at-ici-meeting-2016-300370035.html


'/>"/>
SOURCE BackBeat Medical Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
2. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
3. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
4. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
5. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
6. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
7. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
8. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
9. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
10. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
11. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):